Abstract
We evaluated the incidence, timing, and consequences of urolithiasis in children with acute lymphoblastic leukemia (ALL). A total of 20 patients with urolithiasis were identified from 2095 patients with ALL treated at St Jude Children's Research Hospital on consecutive protocols between 1968 and 1998. For remission induction therapy, all patients received daily prednisone; continuation chemotherapy regimens differed by protocol with some including pulses of prednisone or dexamethasone and others no glucocorticoid. Patients with urolithiasis were older at diagnosis of ALL than those without urolithiasis (median age, 7.5 vs 5.0 years; P=0.03) and less likely to be black (P=0.03) than white or Hispanic, but sex and treatment era did not differ. Presenting symptoms included abdominal or flank pain, hematuria, and dysuria. All stones analyzed biochemically were calcium stones. The incidence of urolithiasis after completion of therapy was 1.8 per 10 000 person-years. Compared to this baseline rate, the relative risk of urolithiasis was 45 (P<0.01) during induction therapy, 22 (P<0.01) during continuation therapy with glucocorticoids, and 5.1 (P>0.05) during continuation therapy without glucocorticoids. Urolithiasis occurred 4.5 times more often during continuation treatment with glucocorticoids than without (P<0.05). Seven patients (35%) had recurrent urolithiasis. Patients with ALL are at risk of developing calcium renal stones during chemotherapy, especially when a glucocorticoid is included.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Schrappe M, Reiter A, Ludwig WD, Harbott J, Zimmermann M, Hiddemann W et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German–Austrian–Swiss ALL-BFM Study Group. Blood 2000; 95: 3310–3322.
Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana–Farber Consortium Protocol 91-01. Blood 2001; 97: 1211–1218.
Pui C-H, Evans WE . Acute lymphoblastic leukemia. N Engl J Med 1998; 339: 605–615.
Pui CH, Mahmoud HH, Rivera GK, Hancock ML, Sandlund JT, Behm FG et al. Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood 1998; 92: 411–415.
Haddy TB, Mosher RB, Reaman GH . Osteoporosis in survivors of acute lymphoblastic leukemia. Oncologist 2001; 6: 278–285.
Kaste SC, Jones-Wallace D, Rose SR, Boyett JM, Lustig RH, Rivera GK et al. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development. Leukemia 2001; 15: 728–734.
Reid IR, Ibbertson HK . Calcium supplements in the prevention of steroid-induced osteoporosis. Am J Clin Nutr 1986; 44: 287–290.
Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N et al. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med 1993; 328: 1747–1752.
van der Veen MJ, Bijlsma JW . Effects of different regimes of corticosteroid treatment on calcium and bone metabolism in rheumatoid arthritis. Clin Rheumatol 1992; 11: 388–392.
Bijlsma JW, Raymakers JA, Mosch C, Hoekstra A, Derksen RH, Baart dlF et al. Effect of oral calcium and vitamin D on glucocorticoid-induced osteopenia. Clin Exp Rheumatol 1988; 6: 113–119.
Pui CH, Roy III S, Noe HN . Urolithiasis in childhood acute leukemia and non-Hodgkin's lymphoma. J Urol 1986; 136: 1052–1054.
Dykman TR, Haralson KM, Gluck OS, Murphy WA, Teitelbaum SL, Hahn TJ et al. Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1984; 27: 1336–1343.
Weisberger AS, Persky L . Renal calculi and uremia as complications of lymphoma. Am J Med Sci 1953; 225: 669–673.
SAS Institute. SAS. SAS/STAT User's Guide, Version 8. Cary, NC: SAS Institute, Inc., 1999.
Sinno K, Boyce WH, Resnick MI . Childhood urolithiasis. J Urol 1979; 121: 662–664.
Bennett AH, Colodny AH . Urinary tract calculi in children. J Urol 1973; 109: 318–320.
Marquardt H, Nagel R . Urolithiasis in childhood. Urology 1977; IX: 627–629.
Diamond DA, Menon M, Lee PH, Rickwood AMK, Johnston JH . Etiological factors in pediatric stone recurrence. J Urol 1989; 142: 606–608.
Musselman PW, Kay R . Urinary tract stones in immobilized children. Cleveland Clin Quart 1985; 52: 11–13.
Stapleton FB, Noe HN, Roy III S, Jerkins G . Hypercalciuria in children with urolithiasis. Am J Dis Child 1982; 136: 675–678.
Noe HN, Stapleton FB, Jerkins GR, Roy III S . Clinical experience with pediatric urolithiasis. J Urol 1983; 129: 1166–1168.
Griffith DP . Infection-induced renal calculi. Kidney Int 1982; 21: 422–430.
Consensus Conference. Prevention and treatment of kidney stones. JAMA 1988; 260: 977–981.
Walther PC, Lamm D, Kaplan GW . Pediatric Urolithiases: a ten-year review. Pediatrics 1980; 65: 1068–1072.
Pui CH, Mahmoud HH, Wiley JM, Woods GM, Leverger G, Camitta B et al. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J Clin Oncol 2001; 19: 697–704.
Asplin JR, Coe FL, Favus MJ . Nephrolithiasis. In: Fauci A, Braunwald E, Isselbacher K, Wilson J, Martin J, Kasper D, Hauser S, Longo D (eds). Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 1998, pp 1569–1574.
Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002; 346: 77–84.
Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CYC . Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 1993; 150: 1761–1764.
Ingelfinger JR . Diet and kidney stones. N Engl J Med 2002; 346: 74–76.
Blatt J, Martini S, Penchansky L . Characteristics of acute lymphoblastic leukemia in children with osteopenia and vertebral compression fractures. J Pediatr 1984; 105: 280–282.
Ribeiro RC, Pui CH, Schell MJ . Vertebral compression fracture as a presenting feature of acute lymphoblastic leukemia in children. Cancer 1988; 61: 589–592.
Strauss AJ, Su JT, Dalton VM, Gelber RD, Sallan SE, Silverman LB . Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 2001; 19: 3066–3072.
Author information
Authors and Affiliations
Additional information
Supported in part by Cancer Center Support (CORE) Grant CA-21765 from the National Cancer Institute, by a Center of Excellence grant from the state of Tennessee, and by the American Lebanese Syrian Associated Charities (ALSAC). C-H Pui is the American Cancer Society-FM Kirby Clinical Research Professor.
Rights and permissions
About this article
Cite this article
Howard, S., Kaplan, S., Razzouk, B. et al. Urolithiasis in pediatric patients with acute lymphoblastic leukemia. Leukemia 17, 541–546 (2003). https://doi.org/10.1038/sj.leu.2402852
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402852
Keywords
This article is cited by
-
Drug-Induced Urolithiasis in Pediatric Patients
Pediatric Drugs (2019)
-
Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment
Drugs (2018)
-
Association of bone mineral density with incidental renal stone in long-term survivors of childhood acute lymphoblastic leukemia
Journal of Cancer Survivorship (2012)
-
Nephrocalcinosis and urolithiasis in children
Kidney International (2011)
-
Asymptomatic kidney stones in long-term survivors of childhood acute lymphoblastic leukemia
Leukemia (2009)